Gastrointestinal Complications in Primary Immunoglobulin Deficiencies

  • Jiri LitzmanEmail author
Part of the Rare Diseases of the Immune System book series (RDIS)


Primary antibody deficiencies (PAD) comprise a broad spectrum of diseases with different pathogenesis, frequently affecting not only immunoglobulin production. Gastrointestinal manifestation is frequent and may lead to significant patient morbidity or even mortality. The causes of complicating gastrointestinal diseases may be divided into three major groups—infections, malignancies, and non-infectious inflammation of autoimmune or non-autoimmune origin. These complications can most frequently be observed in common variable immunodeficiency disorders (CVID). Complication frequency is variable; however, the prevalence increases with the disease duration. Although the majority of GIT diseases can also be observed in immunocompetent patients, in the patients with humoral immunodeficiencies, atypical pictures of these diseases can frequently be seen. In the treatment, antibody replacement is usually not effective, so similar approaches are usually used as with immunocompetent patients.


Antibody deficiency Nodular lymphoid hyperplasia Villous flattening Inflammatory bowel disease 


  1. 1.
    Maarschalk-Ellerbroek LJ, Oldenburg B, Mombers IM, Hoepelman AI, Brosens LA, Offerhaus GJ, et al. Outcome of screening endoscopy in common variable immunodeficiency disorder and X-linked agammaglobulinemia. Endoscopy. 2013;45(4):320–3.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27(3):308–16.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology. 2006;131(3):748–56.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol. 2002;104(3):221–30.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Gathmann B, Mahlaoui N, Gérard L, Oksenhendler E, Warnatz K, Schulze I, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116–26.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Khodadad A, Aghamohammadi A, Parvaneh N, Rezaei N, Mahjoob F, Bashashati M, et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci. 2007;52(11):2977–83.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Hermans PE, Diaz-Buxo JA, Stobo JD. Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients. Am J Med. 1976;61(2):221–37.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Kainulainen L, Nikoskelainen J, Ruuskanen O. Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. J Clin Immunol. 2001;21(2):145–9.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86(1):31–42.PubMedGoogle Scholar
  10. 10.
    Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650–7.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Jørgensen SF, Reims HM, Frydenlund D, Holm K, Paulsen V, Michelsen AE, et al. A cross-sectional study of the prevalence of gastrointestinal symptoms and pathology in patients with common variable immunodeficiency. Am J Gastroenterol. 2016;111(10):1467–75.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Malphettes M, Gérard L, Carmagnat M, Mouillot G, Vince N, Boutboul D, et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009;49(9):1329–38.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Pac M, Bernatowska EA, Kierkuś J, Ryżko JP, Cielecka-Kuszyk J, Jackowska T, et al. Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children – 34-year experience of a single center. Arch Med Sci. 2017;13(2):412–7.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Barmettler S, Otani IM, Minhas J, Abraham RS, Chang Y, Dorsey MJ, et al. Gastrointestinal manifestations in X-linked Agammaglobulinemia. J Clin Immunol. 2017;37(3):287–94.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 2006;85(4):193–202.CrossRefGoogle Scholar
  16. 16.
    Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82(6):373–84.CrossRefGoogle Scholar
  17. 17.
    Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131(1 Pt 1):47–54.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, Deville A, et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol. 2004;110(1):22–9.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Ludvigsson JF, Neovius M, Hammarström L. Risk of infections among 2100 individuals with IgA deficiency: a Nationwide Cohort Study. J Clin Immunol. 2016;36(2):134–40.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46(10):1547–54.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Agarwal S, Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol. 2009;124(4):658–64.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007;31(12):1800–12.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Malamut G, Verkarre V, Suarez F, Viallard JF, Lascaux AS, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol. 2010;105(10):2262–75.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol. 2013;11(9):1050–63.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F, et al. Gastric pathology in patients with common variable immunodeficiency. Gut. 1999;45(1):77–81.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Uzzan M, Ko HM, Mehandru S, Cunningham-Rundles C. Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD). Curr Gastroenterol Rep. 2016;18(4):17.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165(1):1–7.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Magen E, Waitman DA, Goldstein N, Schlesinger M, Dickstein Y, Kahan NR. Helicobacter pylori infection in patients with selective immunoglobulin a deficiency. Clin Exp Immunol. 2016;184(3):332–7.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Pignata C, Budillon G, Monaco G, Nani E, Cuomo R, Parrilli G, et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut. 1990;31(8):879–82.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Ghoshal UC, Goel A, Ghoshal U, Jain M, Misra A, Choudhuri G. Chronic diarrhea and malabsorption due to hypogammaglobulinemia: a report on twelve patients. Indian J Gastroenterol. 2011;30(4):170–4.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Sawatzki M, Peter S, Hess C. Therapy-resistant diarrhea due to Giardia lamblia in a patient with common variable immunodeficiency disease. Digestion. 2007;75(2–3):101–2.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Paranjpe SM, Koticha A, Mehta PR. Chronic Giardiasis in a Case of Common Variable Immunodeficiency (CVID): A Case Report. J Clin Diagn Res. 2016;10(7):DD03–4.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Choi JH, Han DS, Kim J, Yi K, Oh YH, Kim Y. Diffuse nodular lymphoid hyperplasia of the intestine caused by common variable immunodeficiency and refractory giardiasis. Intern Med. 2017;56(3):283–7.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Onbaşi K, Günşar F, Sin AZ, Ardeniz O, Kokuludağ A, Sebik F. Common variable immunodeficiency (CVID) presenting with malabsorption due to giardiasis. Turk J Gastroenterol. 2005;16(2):111–3.PubMedPubMedCentralGoogle Scholar
  35. 35.
    van de Ven AA, Janssen WJ, Schulz LS, van Loon AM, Voorkamp K, Sanders EA, et al. Increased prevalence of gastrointestinal viruses and diminished secretory immunoglobulin a levels in antibody deficiencies. J Clin Immunol. 2014;34(8):962–70.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Woodward JM, Gkrania-Klotsas E, Cordero-Ng AY, Aravinthan A, Bandoh BN, Liu H, et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol. 2015;110(2):320–7.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Kralickova P, Mala E, Vokurkova D, Krcmova I, Pliskova L, Stepanova V, et al. Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports. Int Arch Allergy Immunol. 2014;163(1):69–74.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Ardeniz O, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol. 2009;133(2):198–207.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Boursiquot JN, Gérard L, Malphettes M, Fieschi C, Galicier L, Boutboul D, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol. 2013;33(1):84–95.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59.CrossRefGoogle Scholar
  41. 41.
    Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol. 2002;130(3):495–500.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Kinlen LJ, Webster AD, Bird AG, Haile R, Peto J, Soothill JF, et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet. 1985;1(8423):263–6.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Vajdic CM, Mao L, van Leeuwen MT, Kirkpatrick P, Grulich AE, Riminton S. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood. 2010;116(8):1228–34.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    De Petris G, Dhungel BM, Chen L, Chang YH. Gastric adenocarcinoma in common variable immunodeficiency: features of cancer and associated gastritis may be characteristic of the condition. Int J Surg Pathol. 2014;22(7):600–6.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Ludvigsson JF, Neovius M, Ye W, Hammarström L. IgA deficiency and risk of cancer: a population-based matched cohort study. J Clin Immunol. 2015;35(2):182–8.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Meini A, Pillan NM, Villanacci V, Monafo V, Ugazio AG, Plebani A. Prevalence and diagnosis of celiac disease in IgA-deficient children. Ann Allergy Asthma Immunol. 1996;77(4):333–6.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Jacobson KW, deShazo RD. Selective immunoglobulin A deficiency associated with modular lymphoid hyperplasia. J Allergy Clin Immunol. 1979;64(6 Pt 1):516–21.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Piaścik M, Rydzewska G, Pawlik M, Milewski J, Furmanek MI, Wrońska E, et al. Diffuse nodular lymphoid hyperplasia of the gastrointestinal tract in patient with selective immunoglobulin A deficiency and sarcoid-like syndrome--case report. Adv Med Sci. 2007;52:296–300.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Joo M, Shim SH, Chang SH, Kim H, Chi JG, Kim NH. Nodular lymphoid hyperplasia and histologic changes mimicking celiac disease, collagenous sprue, and lymphocytic colitis in a patient with selective IgA deficiency. Pathol Res Pract. 2009;205(12):876–80.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Postgate A, Despott E, Talbot I, Phillips R, Aylwin A, Fraser C. An unusual cause of diarrhea: diffuse intestinal nodular lymphoid hyperplasia in association with selective immunoglobulin A deficiency (with video). Gastrointest Endosc. 2009;70(1):168–9. discussion 9PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Brandtzaeg P. Update on mucosal immunoglobulin A in gastrointestinal disease. Curr Opin Gastroenterol. 2010;26(6):554–63.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Leven EA, Maffucci P, Ochs HD, Scholl PR, Buckley RH, Fuleihan RL, et al. Hyper IgM syndrome: a report from the USIDNET registry. J Clin Immunol. 2016;36(5):490–501.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Abdel-Naser MB, Wollina U, El Hefnawi MA, Habib MA, El Okby M. Non-sarcoidal, non-tuberculoid granuloma in common variable immunodeficiency. J Drugs Dermatol. 2006;5(4):370–2.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Dalla Torre D, Burtscher D, Jank S, Kloss FR. Necrotizing periodontitis as a possible manifestation of common variable immunodeficiency. Int J Oral Maxillofac Surg. 2012;41(12):1546–9.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Tar I, Kiss C, Maródi L, Márton IJ. Oral and dental conditions of children with selective IgA deficiency. Pediatr Allergy Immunol. 2008;19(1):33–6.PubMedPubMedCentralGoogle Scholar
  56. 56.
    Kalha I, Sellin JH. Common variable immunodeficiency and the gastrointestinal tract. Curr Gastroenterol Rep. 2004;6(5):377–83.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Twomey JJ, Jordan PH, Jarrold T, Trubowitz S, Ritz ND, Conn HO. The syndrome of immunoglobulin deficiency and pernicious anemia. A study of ten cases. Am J Med. 1969;47(3):340–50.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Twomey JJ, Jordan PH, Laughter AH, Meuwissen HJ, Good RA. The gastric disorder in immunoglobulin-deficient patients. Ann Intern Med. 1970;72(4):499–504.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Washington K, Stenzel TT, Buckley RH, Gottfried MR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol. 1996;20(10):1240–52.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Webster AD, Kenwright S, Ballard J, Shiner M, Slavin G, Levi AJ, et al. Nodular lymphoid hyperplasia of the bowel in primary hypogammaglobulinaemia: study of in vivo and in vitro lymphocyte function. Gut. 1977;18(5):364–72.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Albuquerque A. Nodular lymphoid hyperplasia in the gastrointestinal tract in adult patients: a review. World J Gastrointest Endosc. 2014;6(11):534–40.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Garg V, Lipka S, Rizvon K, Singh J, Rashid S, Mustacchia P. Diffuse nodular lymphoid hyperplasia of intestine in selective IgG 2 subclass deficiency, autoimmune thyroiditis, and autoimmune hemolytic anemia: case report and literature review. J Gastrointestin Liver Dis. 2012;21(4):431–4.PubMedPubMedCentralGoogle Scholar
  63. 63.
    Teahon K, Webster AD, Price AB, Weston J, Bjarnason I. Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut. 1994;35(9):1244–9.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Comunoglu N, Kara S, Kepil N. Inflammatory bowel disease-like colitis pathology in a patient with common variable immune deficiency. BMJ Case Rep. 2015;2015:bcr2014207177.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277–86.CrossRefGoogle Scholar
  66. 66.
    Aghamohammadi A, Pouladi N, Parvaneh N, Yeganeh M, Movahedi M, Gharagolou M, et al. Mortality and morbidity in common variable immunodeficiency. J Trop Pediatr. 2007;53(1):32–8.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Woodward J, Gkrania-Klotsas E, Kumararatne D. Chronic norovirus infection and common variable immunodeficiency. Clin Exp Immunol. 2017;188(3):363–70.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Biagi F, Bianchi PI, Zilli A, Marchese A, Luinetti O, Lougaris V, et al. The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study. Am J Clin Pathol. 2012;138(2):185–9.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Luzi G, Zullo A, Iebba F, Rinaldi V, Sanchez Mete L, Muscaritoli M, et al. Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients. Am J Gastroenterol. 2003;98(1):118–21.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Giorgio F, Principi M, Losurdo G, Piscitelli D, Iannone A, Barone M, et al. Seronegative celiac disease and immunoglobulin deficiency: where to look in the submerged iceberg? Nutrients. 2015;7(9):7486–504.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Venhoff N, Emmerich F, Neagu M, Salzer U, Koehn C, Driever S, et al. The role of HLA DQ2 and DQ8 in dissecting celiac-like disease in common variable immunodeficiency. J Clin Immunol. 2013;33(5):909–16.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Elnachef N, McMorris M, Chey WD. Successful treatment of common variable immunodeficiency disorder-associated diarrhea with budesonide: a case report. Am J Gastroenterol. 2007;102(6):1322–5.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Chua I, Standish R, Lear S, Harbord M, Eren E, Raeiszadeh M, et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 2007;150(2):306–11.PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163(3):286–92.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune diseases. Mol Med. 2011;17(11–12):1383–96.PubMedPubMedCentralGoogle Scholar
  76. 76.
    Mohammadi J, Ramanujam R, Jarefors S, Rezaei N, Aghamohammadi A, Gregersen PK, et al. IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype. J Clin Immunol. 2010;30(1):138–43.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Byrne MF, Royston D, Patchett SE. Association of common variable immunodeficiency with atypical collagenous colitis. Eur J Gastroenterol Hepatol. 2003;15(9):1051–3.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, et al. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014;34(6):627–32.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34–48.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Moin M, Aghamohammadi A, Farhoudi A, Pourpak Z, Rezaei N, Movahedi M, et al. X-linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol Investig. 2004;33(1):81–93.CrossRefGoogle Scholar
  81. 81.
    Fuss IJ, Friend J, Yang Z, He JP, Hooda L, Boyer J, et al. Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol. 2013;33(4):748–58.PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Ward C, Lucas M, Piris J, Collier J, Chapel H. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol. 2008;153(3):331–7.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Lal BK, Stanley A. Nodular regenerative hyperplasia related portal hypertension in a patient with hypogammaglobulinaemia. World J Gastroenterol. 2013;19(22):3502–4.PubMedPubMedCentralCrossRefGoogle Scholar
  84. 84.
    Malamut G, Ziol M, Suarez F, Beaugrand M, Viallard JF, Lascaux AS, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol. 2008;48(1):74–82.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Clinical Immunology and Allergology, St Anne’s University Hospital in Brno and Faculty of MedicineMasaryk UniversityBrnoCzech Republic

Personalised recommendations